Merck & Co has provided over 28 million doses of Gardasil to treat HPV with an efficacy rate of 96%+
Register to read the full analysis —or— Upgrade to access more features
#Cancer
#Vaccine
#Research and Development
#HPV
Share this Analysis
Keen to rectify an issue with this analysis?
Report issue